ArticleFrontiers in public health2025
Analysis of reported incidence of chronic hepatitis B in Chaoyang District, Beijing during 2005-2022 with age-period-cohort model.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The study aimed to describe the trend of chronic hepatitis B among the population in Chaoyang District from 2005 to 2022 and explore the effects of age, period, and cohort factors on the incidence risk. Methods: Incidence rates of chronic hepatitis B were collected from the national infectious disease reporting and information management system. Descriptive epidemiological methods were employed to characterize the incidence of chronic hepatitis B from 2005 to 2022. Trends in chronic hepatitis B were analyzed using an age-period-cohort model. The effects of age, period, and cohort on chronic hepatitis B incidence were estimated using the Intrinsic Estimator operator. Model goodness of fit was assessed by introducing variance, AIC, and BIC, comparing the established model with conventional two-factor models. Results: From 2005 to 2022, the reported incidence of chronic hepatitis B in Chaoyang District showed a gradual decrease followed by stabilization, declining from 49.58/100,000 to 8.58/100,000 overall, from 63.36/100,000 to 11.69/100,000 in males, and from 35.15/100,000 to 5.55/100,000 in females. The age effect coefficient for males with chronic hepatitis B increased initially and then decreased with age, whereas for females, it decreased initially and then increased with age. The period effect on chronic hepatitis B incidence risk in both genders initially decreased and then increased over time. The cohort effect coefficient for males exhibited a pattern of decrease, increase, and then decrease, whereas for females, it generally increased and then decreased. The APC model constructed with the intrinsic estimator demonstrated the best goodness of fit, as indicated by lower variance, AIC, and BIC compared to conventional two-factor models. Conclusion: The reported incidence of chronic hepatitis B in Chaoyang District from 2005 to 2022 declined and stabilizing after 2013. We found distinct age, period, and cohort effects on the incidence, with higher risks observed in males aged 25-29 and 75-79, and females born in 1966-1970. These findings highlight the importance of targeted surveillance, expanded screening, and improved diagnosis and treatment rates to reduce the long-term chronic hepatitis B burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.